Common genetic variants in PRRC2A are associated with both neuromyelitis optica spectrum disorder and multiple sclerosis in Han Chinese population

被引：0
|
作者：
Juan Zhang
Mei-Jiao Chen
Gui-Xian Zhao
Hong-Fu Li
Lei Wu
Yong-Feng Xu
Yajin Liao
Zengqiang Yuan
Zhi-Ying Wu
机构：
[1] Zhejiang University School of Medicine,Department of Neurology and Research Center of Neurology in Second Affiliated Hospital, and Key Laboratory of Medical Neurobiology of Zhejiang Province
[2] Fudan University,Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College
[3] Fujian Medical University,Department of Neurology, First Affiliated Hospital
[4] Beijing Institute of Basic Medical Sciences,The Brain Science Center
来源：
Journal of Neurology | 2021年 / 268卷
关键词：
Neuromyelitis optica spectrum disorder; Multiple sclerosis; Chinese;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：506 / 515
页数：9
相关论文
共 50 条
  • [21] Variants of autophagy-related gene 5 are associated with neuromyelitis optica in the Southern Han Chinese population
    Cai, Ping-Ping
    Wang, Hong-Xia
    Zhuang, Jing-Cong
    Liu, Qi-Bing
    Zhao, Gui-Xian
    Li, Zhen-Xin
    Wu, Zhi-Ying
    AUTOIMMUNITY, 2014, 47 (08) : 563 - 566
  • [22] Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
    Kim, Woojun
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2020, 16 (03): : 355 - 368
  • [23] Comparison of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis
    Hyun, Jae-Won
    Jang, Hyunmin
    Yu, JaeBin
    Park, Na Young
    Kim, Su-Hyun
    Huh, So-Young
    Kim, Woojun
    Park, Min Su
    Oh, Jeeyoung
    Park, Kee Duk
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2020, 16 (01): : 124 - 130
  • [24] Efficacy and Safety of Rituximab in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
    Ongphichetmetha, Tatchaporn
    Jitprapaikulsan, Jiraporn
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (09) : NP3 - NP4
  • [25] Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder
    Uzawa, A.
    Mori, M.
    Masuda, H.
    Ohtani, R.
    Uchida, T.
    Aoki, R.
    Kuwabara, S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2020, 202 (02): : 239 - 248
  • [26] Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach
    Ota, Miho
    Sato, Noriko
    Okamoto, Tomoko
    Noda, Takamasa
    Araki, Manabu
    Yamamura, Takashi
    Kunugi, Hiroshi
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2015, 4 (06) : 515 - 520
  • [27] Efficacy and safety of rituximab in multiple sclerosis and neuromyelitis optica spectrum disorder
    Tatchaporn Ongphichetmetha
    Jiraporn Jitprapaikulsan
    Sasitorn Siritho
    Natthapon Rattanathamsakul
    Thammachet Detweeratham
    Naraporn Prayoonwiwat
    Scientific Reports, 14
  • [28] Quantitative Susceptibility Mapping in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
    Kim, W.
    Lee, J. E.
    Lee, K. S.
    Nam, Y.
    Jang, J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 438 - 438
  • [29] Comparison of neuropathic pain in neuromyelitis optica spectrum disorder and multiple sclerosis
    Hyun, J. -W.
    Jang, H.
    Yu, J.
    Park, N. Y.
    Kim, S. -H.
    Huh, S. -Y.
    Kim, W.
    Park, M. S.
    Oh, J.
    Park, K. D.
    Kim, H. J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 401 - 402
  • [30] Prevalences and incidences of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea
    Kim, Jee-Eun
    Park, Sang-hyun
    Han, Kyungdo
    Kim, Ho-Jin
    Shin, Dong-wook
    Kim, Sung-Min
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP44 - NP44
12345